It also led to a significant reduction in the autophagy biomarkers Beclin1 and p62, which indicates an increase in autophagy flux [21] Fig
Learn more about the side effects of semaglutide (Ozempic)
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
Employers and insurers are gaining relevance as they seek programs that combine prescribing with coaching and measurable outcomes
Employers seek solutions While these drugs represent a small fraction of prescriptions, their financial impact is outsized
This is the adjustment period when your body is learning to function with slower digestion and different hunger signals